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THE INFLUENCE OF PAIN-RELATED FEAR LEVELS ON STRUCTURAL 
BRAIN CHANGES IN PEDIATRIC COMPLEX REGIONAL PAIN SYNDROME 
 
KUNYU ZHANG 
 
 
 
ABSTRACT 
 Complex Regional Pain Syndrome (CRPS) is a chronic neuropathic pain 
condition associated with significant alterations in the somatosensory and motor cortex 
brain regions. Cognitive-affective alterations have recently been recognized in patients 
suffering with CRPS, however, relatively little neuroimaging research has been done to 
examine these dimensions. Moreover, many children and adolescents suffer from CRPS, 
but very little is known about the impact of this condition on brain states in the pediatric 
population. The aim of this paper is to assess the structural brain differences between 
children with CRPS and healthy controls and to examine to what degree fear level 
influences such differences. This study is part of a larger investigation that integrates 
functional and structural brain differences to evaluate fear-related brain circuitry in 
patients with CRPS. Thirty-seven patients with CRPS were age and gender matched with 
35 healthy controls. The two groups underwent structural magnetic resonance imaging 
(MRI) scans as well as completed the Fear of Pain Questionnaire, child report (FOPQ). 
To examine gray matter differences, voxel-based morphometry (VBM) 
and cortical thickness (CT) analysis was completed. Patients with CRPS in this study had 
an average age of 13.2 (SD=2.7) and were predominantly female (73%). Of the 35 
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patients who completed FOPQ, 49% reported clinically significant pain-related fear. 
Compared with healthy controls, CRPS patients had significantly less in gray matter 
(GM) volume in pain- and fear-related brain regions, including the dorsolateral prefrontal 
gyrus, motor and somatosensory cortex, anterior and posterior cingulate cortex, nucleus 
accumbens, putamen, amygdala, and hippocampus. Furthermore, gray matter decreases in 
regions such as anterior midcingulate cortex, nucleus accumbens, and putamen were 
associated with elevated pain-related fear in patients. Differences in gray matter volume 
in fear-circuitry areas could potentially be one mechanism by which abnormal fear 
learning and extinction develops in youth suffering with CRPS. Further research 
examining brain changes post-treatment is needed to determine if treatments that target 
improving pain and fear levels are associated with concomitant normalization of brain 
structures.  
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INTRODUCTION 
 
 Pain is a commonplace experience that is well known to almost every individual. 
Acute pain is usually caused by an inciting event, such as an injury or inflammation, and 
dissipates once the injury is healed or inflammation subsides. Chronic pain, on the other 
hand, endures even in the absence of inflammation or tissue injury. According to the 
National Institutes of Heath Pain Consortium, the public health burden of pain affects 
one-third of Americans and costs up to $635 billion each year 
(www.painconsortium.nih.gov).  
 
Acute to Chronic Pain 
 Normally, the healing process occurs after an acute injury through inflammatory 
reaction, tissue restoration, and tissue remodeling, which lead to a resolution of the injury 
as well as pain sensation (Li et al., 2007). However, the transition from acute to chronic 
injury stems from an interruption in this process. Pathophysiology and 
histolopathological steps alter the afferent nociceptive information, leading to a reduced 
ability to inhibit pain impulses that normally produce an analgesic effect. Neuroplasticity 
of the central nervous system plays a key role in prolonging the peripheral lesion through 
continually sending signals to the spinal cord and eventually higher brain areas, 
remodeling and intensifying nociceptive transmission (Voscopoulos and Lema, 2010).  
 Although the transition to chronic pain involves an essential event of central 
sensitization that increases spinal cord inputs to the brain, many cognitive, affective, and 
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psychosocial factors play an important role in the development of chronic pain as well. In 
a study by Young Casey and colleagues (2008) who looked at the transition from acute to 
chronic pain and disability in neck and back pain, depressed mood and greater exposure 
to past traumatic life events were most predictive of chronic pain, whereas depressed 
mood and negative pain beliefs were most predictive of chronic disability (Young Casey 
et al., 2008). Chronic pain leads to cognitive and behavioral impairments that are 
oftentimes disproportional to the initial inciting event, causing increased anxiety, 
depression, and a reduced quality of life. Although pharmaceutical drugs are deemed 
highly effective in targeting acute pain, there does not seem to be a consistent 
pharmacological treatment for chronic pain. The reason is that such drugs aims to 
alleviate inflammation and local analgesia, which may relieve the initial injury but do 
little to affect pain in chronic conditions. Mansour and colleagues (2014) suggest that 
chronic pain is the consequence of plastic changes in cortical-limbic circuitry. While 
patients are in pain from their acute injury, aversive stimuli create salient memories and 
associations that translate into new learning of pain in other areas of life that is 
continually reinforced by their current pain (Mansour et al., 2014). Therefore, it is 
worthwhile to examine the structural and functional brain changes in patients with 
chronic pain in order to correlate such physical differences with clinical symptoms.  
 
Brain Changes in Chronic Pain 
 In studies that have examined brain changes in chronic pain, involvement of both 
emotional circuitry and cortical reorganization is critical. A novel hypothesis proposed by 
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Mansour and colleagues (2014) suggests that chronic pain is a state of continuous 
learning. Acute pain perception involves activation of the anterior cingulate cortex (ACC) 
and insula as well as the limbic circuitry. The limbic circuitry includes a number of 
subcortical brain regions that are in constant communication with each other, driving 
emotion and behavior. The nucleus accumbens (NAc) plays a central role in the reward 
circuitry based on two neurotransmitters dopamine and serotonin, which promote desire 
and satiety, respectively (thebrain.mcgill.ca). The amygdala (Amyg) is the major region 
of emotions and arousal and is implicated as the center of negative affect (Simons et al., 
2014). It is intricately connected to the hippocampus, the hub for memory. In the case of 
pain, the limbic system works together to promote fear learning. Although learning takes 
place in healthy patients, it is effectively extinguished over time with a concomitant 
resolution of pain. However, in development of chronic pain, the synaptic pathways 
enforced by learning interact with prefrontal cortex, specifically the medial and lateral 
areas, shifting nociceptive perception to an emotional suffering state. The lateral 
prefrontal cortex is involved in goal-directed and stimulus-driven attention (Asplund et 
al., 2010) while the medial prefrontal cortex plays a large role in memory and decision-
making (Euston et al., 2012). The prefrontal cortex circuitry in turn influences cortical 
reorganization as a result of continual suffering and coping mechanism employed by the 
patient (Mansour et al., 2014). Over time, the persistent involvement of the limbic-
cortical and prefrontal circuitry induces structural and functional brain changes in chronic 
pain patients.  
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As brain imaging methods advance, it has become possible to investigate potential 
morphometric brain region changes by comparing patients in chronic pain with healthy 
controls. Apkarian and colleagues (2004) observed that patients with chronic back pain 
(CBP) demonstrated impaired emotional decision-making that correlated with the 
magnitude of their back pain, suggesting that their pain extended to their ability to make 
decisions in other emotional tasks. In analyzing functional magnetic resonance imaging 
(fMRI) of these patients, they found that spontaneous pain engages the medial prefrontal 
cortex (mPFC) as well as the NAc. Interestingly, when comparing patients with healthy 
controls, deactivation of the NAc in response to a nociceptive cue was observed in 
patients, implying an abnormal pain processing mechanism in CBP patients (Apkarian et 
al., 2004).  
In another study investigating structural and functional brain changes in 
fibromyalgia (FM) patients, Jensen and colleagues (2013) concluded that central 
plasticity is critical for the transition from acute to chronic pain. When compared to 
healthy controls, FM patients exhibited decreased cortical thickness, brain volume, and 
functional regional coherence in the rostral anterior cingulate cortex (rACC). The rACC 
plays a key role in descending inhibition of pain. The changes seen in FM patients may 
therefore indicate an abnormal dysfunction of descending pain modulation (Julien et al., 
2005). Increased morphometric changes were associated with longer FM pain duration, 
indicating that long-term exposure to pain causes reduction in both activity and gray 
matter (GM) volumes in certain brain regions (Rodriguez-Raecke et al., 2009). In 
addition, brain changes in the mesolimbic system were associated with severity of 
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comorbid depression symptoms, which suggests that depression symptoms are associated 
with cerebral changes, independent of pain (Jensen et al., 2013). 
 
Pediatric Chronic Pain 
 Chronic pain in children and adolescents has a prevalence rate of 11-38% (King et 
al., 2011). Chronic pain is especially impressionable on children because it influences 
cognitive and social development in a period that is particularly vulnerable to change. 
Moreover, the peak onset of pediatric chronic pain occurs in adolescents (King et al., 
2011). Factors such as increased susceptibility to fear learning can result in pain 
persistence, treatment resistance, and increase risk of continuation of chronic pain 
condition into adulthood (Pattwell et al., 2012).    
 In a recent review by Goubert and Simons (2013), the determinant of chronicity 
of pain experience in pediatrics depends heavily on the cognitive styles of both the child 
and parents. Goubert and Simons suggested that the pain outcome is determined by the 
way an individual perceives and interprets pain. Primarily, a fearful temperament and 
pessimistic outlook are associated with poorer mental health and more long-term somatic 
pain (Goubert and Simons, 2013). Catastrophic thinking, specifically “focusing and 
exaggerating the threat value of painful stimuli and negatively evaluating one’s own 
ability to deal with pain” (Sullivan et al., 2001), is predictive of persistence of pain and 
disability (Linton et al., 2000). Child catastrophizing may manifest in the way the child 
expresses his or her pain experience, which provokes anxious and protective behaviors of 
parents and may further encourage fear-avoidance beliefs and behavior of the child. This 
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cycle ultimately leads to maintenance of pain experience and increased functional 
disability (Goubert and Simons, 2013).  
 With the continuance of such fear-avoidant cognition and motivation, it follows 
that the presence of chronic pain will undoubtedly influence areas of the brain mediating 
pain perception and emotion circuitry. Based on the relatively high plasticity of pediatric 
brain (www.albertafamilywellness.org), the impact of chronic pain may have different 
magnitude and direction and may affect dissimilar brain regions than the corresponding 
pain conditions in adults. Unfortunately, there is a relative small amount of literature that 
has examined the brain changes in pediatric chronic pain disorders, furthering the need to 
do so in the current study.    
 
Complex Regional Pain Syndrome (CRPS) 
 Complex Regional Pain Syndrome (CRPS) is a neuropathic pain condition that is 
characterized by burning and exaggerated painful sensation (hyperalgesia) and pain in 
response to non-painful stimulus (allodynia) (Birklein et al., 2000). Other autonomic 
symptoms may accompany the condition: sweating, edema, change in skin color, and 
temperature change. In addition, motor disturbances, such as weakness, tremor, and 
muscle spasms may be present (Veldman et al., 1993).  
CRPS typically develop after an inciting injury and affects the corresponding part 
of the body. However, in some cases, the condition is developed idiopathically in less 
than 5% of patients (Veldman et al., 1993). Two types of CRPS are diagnosed. CRPS-1, 
formally known as reflex sympathetic dystrophy or Sudeck’s atrophy, precipitates 
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without identifiable peripheral nerve damage. In CRPS-2, formally known as causalgia, 
neural damage can be identified (Stanton-Hicks et al., 1995).  
Several studies investigated the incidence of CRPS and found that women ages 
61-70 years are at most risk. Upper limb is more frequently affected than lower limb (de 
Mos et al., 2007; Sandroni et al., 2003). In studies that tested the efficacy of a range of 
treatment for CRPS, it was found that sympathetic suppression, radical scavenging, and 
acupuncture had limited results, whereas interventions involving exercise and calcium-
regulating drugs proved most effective (Forouzanfar et al., 2002; Perez et al., 2001). 
Current treatment takes on a multidisciplinary approach that involves cognitive-
behavioral therapy, such as relaxation training and readjusting catastrophizing cognition, 
as well as continuation of pharmaceutical drugs (Bruehl and Chung, 2006).   
 
Brain Changes in CRPS 
 Several studies have assessed neural organization of patients with CRPS and 
possible treatment approaches aimed to specifically target cortical changes. In a study by 
Swart and colleagues (2009), cortical involvement of CRPS was found to include 
mislocalizations of tactile stimuli, changes in size and organization of the somatosensory 
map, changes in motor cortex representation, and body perception disturbances. Swart 
and colleagues concluded that the pain of patients with CRPS is a result of a mismatch 
between motor intention and incorrect sensory feedback of the affected limb. The chronic 
development of this pain condition is essentially a self-perpetuation of motor cortex 
reorganization that is caused by this incongruence of efferent and afferent inputs, and the 
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consequential disuse of the affected body part that leads to further reorganization of the 
cortex (Swart et al., 2008). Therefore, therapies that aim to resolve this mismatch, for 
example, mirror therapy (Ramachandran and Hirstein, 1998) or motor imagery 
programming, (Moseley, 2004) will eventually restore the disorganized body scheme 
(Harris, 1999).  
 Several other studies have taken a neuroimaging approach to examine structural 
brain changes in patients with CRPS that involve both gray matter (GM) and white matter 
(WM) changes as well as differences in functional connectivity. In a pioneering study, 
Geha and colleagues (2008) found GM atrophy in the right anterior insula (AI), right 
ventromedial prefrontal cortex (vmPFC), and right nucleus accumbens (NAc). 
Correlation studies associated right AI with duration of CRPS pain (Geha et al., 2008). 
Since the insula is activated in acute pain tasks (Apkarian et al., 2005) and its activation 
correlated with ratings of allodynia and hyperalgesia (Maihöfner et al., 2005), alteration 
in AI may point to abnormal autonomic function. The right AI is also implicated in 
emotional representation and correlates with subjective ratings of visceral awareness 
(Critchley et al., 2005), suggesting that atrophy in the right AI supports the clinical 
finding of negative emotional state of patients with CRPS. Atrophy in vmPFC correlates 
with duration and intensity of CRPS pain (Geha et al., 2008). Neurons in the vmPFC 
project to the hypothalamus and brainstem areas that link autonomic regulation with 
emotional responses (Ongür and Price, 2000), as well as the periaqueductal gray in 
modulating nociceptive inputs (An et al., 1998). Taken together, these findings suggest 
	  9 
that the alterations in GM density in the AI and vmPFC are involved in pain 
manifestation and autonomic irregularities in patients with CRPS.   
Other studies have found contradictory results for the direction of brain changes 
or the differences in affected cortical regions. In their study, Pleger et al. (2014) 
concluded that CRPS affects brain structures in the prefrontal and motor cortex. More 
specifically, patients with CRPS showed an increase in GM density in the dorsomedial 
prefrontal cortex (dmPFC), as well as an increase in GM density in the primary motor 
cortex (M1) contralateral to the affected limb. Since the dmPFC is involved in coding 
emotional correlates of pain (Porro et al., 2003) and top-down modulation of central pain 
networks (Napadow et al., 2009), the increased GM density of dmPFC can be seen as a 
result of a response to the emotional process involved in modulating pain (Pleger et al., 
2014). An increased GM density in M1 has been shown to correlate with individual 
extent of motor dysfunction (Maihöfner et al., 2007), therefore reflecting an amplified 
activation in motor response. In examining gray-white matter interaction between motor 
cortex and internal capsule, Pleger and colleagues (2014) found that an increase in GM 
density in M1 was associated with a decrease in WM density in the ipsilateral internal 
capsule. This finding possibly suggests a compensatory mechanism of the central motor 
system caused by motor dysfunction (Pleger et al., 2014).  
 A study by Barad and colleagues (2014) examined structural abnormalities 
specifically in pain-related regions. The analysis yielded the following findings: (1) 
decreased GM volume in the dorsal insula, left orbitofrontal cortex (OFC), and cingulate 
cortex, and (2) increased GM volume in the bilateral dorsal putamen and right 
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hypothalamus. Regions such as the cingulate and the OFC are found in the limbic system 
and are implicated in the general pain population (Ruscheweyh et al., 2011). Volumetric 
abnormalities of the limbic system also suggest dysregulated emotional processing of 
pain information in CRPS (Barad et al., 2014). The pregenual anterior cingulate cortex is 
involved with unpleasantness and suffering (Ploner et al., 2002), while the OFC exhibits 
an increase in activation during expectation of pain (Mohr et al., 2005). An increased GM 
volume in the putamen, an area involved in processing pain (Brooks et al., 2005), could 
be driven by a compensatory action against sustained nociceptive input (Barad et al., 
2014). Increase in hypothalamus GM volume could be responsible for the irregular 
autonomic symptoms in CRPS (Lebel et al., 2008). 
 
Pediatric Complex Regional Pain Syndrome 
 CRPS is also found in children and adults, albeit it is a rarer condition. Although 
it is well characterized in adults, pediatric CRPS is a relatively new diagnostic entity (Tan 
et al., 2008). There are several notable differences in the disease state between pediatrics 
and adults. The lower limb is more frequently affected (Low et al., 2007), the skin 
temperature of the limb is often cooler, and there are less pronounced neurological and 
sympathetic symptoms (Tan et al., 2008). In addition, significant trauma is much less 
frequently a precipitating event than in adults (Wilder et al., 1992). CRPS in pediatrics, as 
in the adult population, predominantly affects females (Low et al., 2007). 
 When examining the prognosis of pediatric CRPS, children have shown better 
response to noninvasive treatment (Murray et al., 2000), and psychosocial factors play a 
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greater role in the outcome of treatment (Wesdock, 1991). Several studies have reviewed 
an array of treatment approaches and compared them for efficacy. Kachko et al., (2008) 
found that early recognition and management are major factors in improving the outcome 
of CRPS. Early psychological evaluation and cognitive behavior treatment are crucial to 
preventing resistant CRPS (Kachko et al., 2008). In another study, Low et al., (2007) 
concluded that a combination of physiotherapy, psychological intervention, and 
medication, as well as an early diagnosis (average of 5 weeks), is key to a shorter time to 
symptom resolution (average 10 weeks). Interestingly, bone scans are also a useful 
diagnostic and prognostic tool. Diffuse hypoperfusion achieved symptom resolution in a 
shorter time (average 12.2 weeks) compared with patients with normal or hyperperfusion 
scans (average 16 and 28.4 weeks, respectively) (Low et al., 2007).  
As previously mentioned, most children achieve full recovery either 
spontaneously or through therapeutic interventions within a year (Low et al., 2007). 
Because of the resiliency of the nervous systems of children and the modifiable nature of 
their brain changes (Becerra et a., 2014), pediatric patients with CRPS make excellent 
candidates for neuroimaging studies to investigate brain changes pre- and post-treatment  
and to examine morphometric and functional alterations as they correspond to treatment 
outcomes.  
Erpelding and colleagues (2014) examined the differences in brain functionality 
and structure in pediatric patients with CRPS. A combination of a cross-sectional study 
and longitudinal study was conducted in order to assess disease effect (comparing 
patients and healthy controls) and treatment effect (comparing patients pre- and post-
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treatment). When compared with healthy controls, patients with CRPS had significant 
GM differences in pain-related cortical areas including dorsolateral prefrontal cortex 
(dlPFC), motor (M1) and somatosensory cortex (S1), regions within anterior (ACC) and 
posterior cingulate cortex (PCC). Furthermore, patients exhibited reduced GM volumes 
in clusters of subcortical regions including caudate (Cau), putamen (Put), nucleus 
accumbens (NAc), anterior thalamus (Thal), amygdala (Amy), and anterior hippocampus 
(Hippo), providing possible markers for a disease state brain. When brain structure was 
assessed post-treatment, patients showed significant reversal of some structural 
alterations, including increased GM in the dlPFC, Put, Cau, and Thal, that correlated with 
behavioral improvements (Erpelding et al., 2014). These results suggest that such rapid 
brain changes may be indicative of improvement of the disease state.  
 
Influence of Fear in Context of Pain 
 When assessing treatment outcome in patients with chronic pain, psychological 
factors, specifically pain-related fear and avoidance, play an important role in progress 
and persistence of pain-related disability in the adult population (Leeuw et al., 2007). 
Simons and Kaczynski (2012) also found this to be true in children and adolescents with 
chronic pain. In their study examining associations with treatment response in the context 
of intensive pain rehabilitation, pain-related fear was significantly associated with 
disability and depressive symptoms. Furthermore, high levels of pain-related fear at 
baseline predicted worse treatment response as measured by less reduction in functional 
disability and depression at discharge (Simons and Kaczynski, 2012).  
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 A possible explanation that provides a link between pain-related fear and 
treatment response can be demonstrated in the fear-avoidance model (FAM) of chronic 
pain, modified for pediatric patients (Simons and Kaczynski, 2012). Patients who develop 
fear-of-pain tend to experience events such as hypervigilance and guarding behaviors that 
maintains their pain, leading to avoidance and eventually disuse, disability, and 
depression (Leeuw et al., 2007). On the other hand, if patients continue with physical 
activities, testing and correcting their pain expectations, pain symptoms are likely to 
resolve (Lohnberg, 2007).  
 
Figure 1: Fear-avoidance model of chronic pain. Predictive components, pain catastrophizing 
and pain-related fear, have been shown to be predictive components of pain-related disability. 
Adapted from Simons et al., 2012. 
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A validated and reliable measure used to evaluate pain-related fear and avoidance 
in pediatric chronic pain patients is the Fear of Pain Questionnaire (FOPQ; Simons et al., 
2011). The psychological measure is subdivided into two scores: Fear of Pain and 
Avoidance of Activities, and will be used in this study as the principal measurement to 
assess patient level of fear. 
  
Pain-Related Fear Circuitry 
 Advances in neuroimaging technique have made it possible to examine brain 
structures and functional connectivity as they relate to pain and analgesia. Regions such 
as the somatosensory cortex, thalamus, insula, anterior cingulate cortex, and prefrontal 
cortex have been consistently implicated in the pain process, with recent discoveries of 
involvement of subcortical areas such as the hippocampus, basal ganglia, and amygdala 
(Simons et al., 2014). The amygdala is well known as the hub of negative affect, 
receiving pain stimuli and attaching emotional significance to sensory information (Paré 
et al., 2004). Within the amygdala, the lateral nucleus connects with the centromedial 
nucleus to control expression of conditioned fear responses. The prefrontal cortical areas, 
such as ventromedial prefrontal cortex (vmPFC), project to the lateral nucleus of the 
amygdala, demonstrating a cognitive component of memories and expectations for pain. 
The vmPFC along with the intercalated cells are also responsible for inhibition of fear 
expression through connections with the centromedial nucleus of the amygdala. The 
hippocampus projects to the basal nucleus of the amygdala and is involved in processing 
contextual information during fear conditioning (Simons et al., 2014). The lateral nucleus 
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of the amygdala also receives projections from the anterior cingulate cortex, which is 
involved in affective processing, selection of motor responses, and memory to predict and 
avoid pain (Devinsky et al., 1995).  
 
Figure 2: Neural pathways of fear learning. The lateral nucleus (LA) connects with the 
centromedial nucleus (CeM), controlling expression of conditioned fear responses. Projectsion 
exist from ventromedial prefrontal cortex (vmPFC), insula, anterior cingulate cortex (ACC), and 
hippocampus to LA. Additional projections exist between hippocampus to basal nucleus (B). 
Intercalated cells (ITC). Adapted from Simons et al., 2014 
 
The Present Study 
 The present data and analysis are part of a larger investigation that integrates 
functional and structural brain differences to evaluate fear-related brain circuitry in 
patients with CRPS. Our patient population consists of patients with CRPS recruited 
primarily from the Pain Treatment Service and Pediatric Pain Rehabilitation Center at 
Boston Children’s Hospital (Boston, MA). Our goal is to establish structural and 
functional differences in pediatric chronic pain patients compared with healthy controls 
and to evaluate the unique influence that pain-related fear plays on brain morphometry. 
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The specific focus of the current study aims to examine structural differences present in 
patient brains and to determine the degree to which fear level corresponds to such 
morphometric changes.  In doing so, we hope to establish differences in brain structures 
as indicators of disease state that could provide insight for prognosis and treatment 
response.  
 
Specific Aims  
In this current study, we aim to: 
(1) Examine structural brain differences between patients with CRPS and matched 
healthy controls. 
(2) Investigate the influence of fear level by assessing structural brain differences 
in patients with high fear and non-elevated fear and by comparing them with healthy 
controls. 
 
We hypothesize that the study will show: 
(1) The existence of a significant difference in brain structures, especially in pain- 
and fear-related regions (e.g. dlPFC, M1, S1, Amy, Hippo) between patients and healthy 
controls. 
(2) The importance of the high fear group in driving the differences in brain 
structures when compared with non-elevated fear patients and healthy control. 
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METHODS 
 
Participants 
A total of 37 patients with CRPS were recruited from the Chronic Pain Clinic in 
the Pain Treatment Service at Boston Children’s Hospital (BCH) for this BCH 
Institutional Review Board approved study. Both the patient and a parent gave consented 
for this study. Parents were present during the study visits. Patients were included in the 
study if (1) they refrained from using analgesic medication more than 4 hours prior to the 
study session, (2) they experienced unilateral lower extremity CRPS (based on Budapest 
criteria; Harden et al., 2010), and (3) their pain intensity was greater than 5 on a 11-point 
numerical rating scale (NRS). They were excluded from the study if they had (1) 
claustrophobia, (2) significant medical problems (e.g., uncontrollable asthma and 
seizures, cardiac diseases, severe psychiatric disorders, and neurological disorders other 
than CRPS), (3) pregnancy, (4) medical implants, devices, or both and (5) weight more 
than 285 pounds which corresponded to the weight limit of the magnetic resonance 
imagining (MRI) table. Gender- and age-matched healthy controls (n=35) were recruited 
in the greater Boston area through advertisements. Each study session consisted of a 
neurological exam with a study physician, questionnaires, and an MRI scan.  
 
Fear of Pain Measure 
The Fear of Pain Questionnaire (FOPQ) (Simons et al., 2011) is a self-report 
inventory to assess pain-related fears. Each item is rated on a 5-point Likert-type scale 
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from 0 = “strongly disagree” to 4 = “strongly agree.” The FOPQ consists of 24 items with 
strong internal consistency (α =0 .92). The measure has two subscales: Fear of Pain (α = 
0.89) and Avoidance of Activities (α = 0.86). Construct validity for this measure is 
supported with significant relations found for the FOPQ with child somatization, anxiety, 
and catastrophizing. Criterion-related validity is also supported with significant relations 
between higher FOPQ scores and greater functional disability and more frequent doctor 
visits in the previous three months. Stability of the FOPQ total scale score is adequate (α 
=0 .74) with decreases in FOPQ scores associated with concomitant decreases in 
functional disability (r = 0.45) at one-month follow-up, suggesting sensitivity to 
treatment response (Simons et al., 2011).  High fear (FOPQ≥50) and non-elevated fear 
(FOPQ<50) groups used in this study were defined from tertiles in the validation sample 
(Simons et al., 2011).   
 
Brain Imaging and Data Analysis 
MRI Acquisition 
Subjects underwent MRI on a 3T scanner (Siemens Medical Solutions, Erlangen, 
Germany) using a 12-channel head coil. For each participant, we collected a 3D T1-
weighted anatomical scan using a magnetization-prepared rapid acquisition gradient echo 
(MPRAGE) sequence (128 slices; repetition time (TR) = 2100 ms; time to echo (TE) = 
2.74 ms; time for inversion (TI) = 1100 ms; 256 × 256 matrix; field of view (FOV) = 200 
mm; 1.33 × 1.0 × 1.0 mm voxels). Subjects were instructed to relax with their eyes open 
looking at a blank screen.  
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MRI Preprocessing and Data Analysis 
Cortical Thickness  
To analyze whether patients exhibited cortical GM alterations compared with 
healthy control subjects and by pain-related fear level, we performed cortical thickness 
analysis using FreeSurfer software (http://surfer.nmr.mgh.harvard.edu). MPRAGE 
preprocessing steps included (1) intensity normalization, (2) skull stripping, (3) Talairach 
transformation, (4) hemispheric separation, (5) tissue segmentation, (6) identification of 
white surface and pial surface, (7) cortical parcellation, and (8) registration to the average 
surface map. Finally, a 10-mm full-width half-maximum (FWHM) Gaussian smoothing 
kernel was applied. Cortical thickness analysis was performed at the whole brain level. 
Results were corrected for multiple comparisons based on Monte Carlo permutations 
with 5,000 iterations using the AlphaSim program 
(http://afni.nimh.nih.gov/afni/doc/manual/AlphaSim). With an image-wide threshold of p 
< 0.01 and a Bonferroni-corrected p < 0.025 (to correct for each hemisphere), AlphaSim 
simulations revealed that 76 contiguous vertices were required for clusters to be 
significant.  
 
Subcortical Volume 
To investigate subcortical GM volume differences by pain-related fear level 
among patients and in contrast to controls, we used two approaches: (1) whole structure 
subcortical volumes derived in the FreeSurfer processing stream (aseg stats) and (2) 
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voxel-based morphometry (VBM) using FSL-VBM (Functional Magnetic Resonance 
Imaging of the Brain (FMRIB) Software Library-VBM) (Douaud et al., 2007) to examine 
differences within subcortical structures. For VBM, preprocessing steps included (1) 
brain extraction using an optimized brain extraction tool (optiBET) script (Lutkenhoff et 
al., 2014), (2) tissue-type segmentation into GM, white matter (WM), and cerebrospinal 
fluid (CSF), (3) nonlinear registration of GM partial volume maps to MNI152 standard 
space, (4) creation of a study-specific GM template, (5) nonlinear registration of GM 
images to study-specific GM template, and (6) modulation to correct for local expansion 
or contraction (i.e., by dividing them by the Jacobian of the warp field). Finally, the 
modulated registered GM images were smoothed with a FHWM kernel of 7.05 mm (i.e., 
sigma = 3). To control for variability in head size, the total intracranial volume (TIV) was 
extracted for each subject and entered as a variable of no interest for subcortical gray 
matter volume (GMV). To correct for multiple comparisons, the voxelwise threshold of 
significance was set at p values less than 0.05 when corrected for family-wise error 
(FEW) at the cluster level. 
 
ROI Analysis  
To increase power in our study, we conducted region-of-interest (ROI) analysis 
using a subcortical mask that contained the thalamus (Thal), caudate (Cau), putamen 
(Put), hippocampus (Hippo), nucleus accumbens (NAc), amygdala (Amy), and 
hypothalamus (Hypo). We also included the cingulate cortex, both anterior (ACC) and 
posterior (PCC). Selection of these regions was based on results from recent work 
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identifying these regions as having stronger synchronicity in activity with the amygdala 
at rest in pediatric CRPS (Simons et al., 2014). Masks for ROI analysis were created 
using the Harvard–Oxford Subcortical Structural Atlas in FSL 
(http://www.cma.mgh.harvard.edu/). When analyzing mean group differences between 
high fear patients, non-elevated fear patients, and healthy controls, FSL general linear 
model (GLM) F-test was conducted. If the F-test was significant, individual t-tests (i.e. 
high fear versus non-elevated fear, high fear versus healthy controls, and non-elevated 
fear versus healthy controls) were then used to determine the direction of the effect.   
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RESULTS 
 
Participants 
All 37 patients and 35 healthy controls were included for the cortical thickness 
and gray matter volume analysis. Within this sample, a subsample of 12 patients with 
CRPS had been previously used to investigate functional connectivity changes of specific 
brain regions (i.e., habenula, amygdala) (Erpelding et al., 2014; Simons, et al., 2014). 
Also, structural data from 23 patients and 21 controls had been previously reported 
(Erpelding et al., 2014). Of note, half of the patient brains had been flipped in the 
Erpelding et al. (2014), analysis to control for affected side in examining impact of 
disease state on brain structures, notably the somatosensory and motor cortices where 
laterality may act as a confounding variable. Given that the current study focuses on 
emotional circuitry and possible sidedness of such processing, brains were not flipped for 
this analysis.  
Among the 37 patients with CRPS in the study, 73% were female with age range 
from 8-20 years (mean ± SD age 13.2 ± 2.7 years). This was commensurated with the 
matched healthy controls (77% female; mean ± SD age 13.4 ± 2.8 years). All patients 
with CRPS had a unilateral lower extremity affected limb (57% on the left side). 
Duration of pain ranged from 1-85 months (mean ± SD duration 13.2 ± 17.5 months). All 
study participants were right-handed. 
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Pain and Pain-Related Fear 
Among the 37 patients, 89% of patients reported moderate (38%; VAS rating 4-6) 
to severe (51%; VAS rating 7-10) average pain levels (mean ± SD VAS 6.4 ± 2.1). 
Among the 35 patients who completed the FOPQ, 49% reported clinically significant 
pain-related fear (mean ± SD FOPQ 61 ± 7.3). To investigate the effect of fear levels on 
structural brain changes, we placed patients with FOPQ≥50 into a high fear group and 
patients with FOPQ<50 into a non-elevated fear group. Pain-related fear and pain were 
not statistically significantly associated with one another (r=0.13, p=0.45). 
 
Patients Versus Healthy Controls 
Cortical Thickness 
 There were several significant cortical differences between patients and controls 
with thinner cortices observed in each instance among patients. Compared with healthy 
controls, patients exhibited less cortical GM in pain-related brain regions such as the 
precentral gyrus (PreCG), postcentral gyrus (PoCG), paracentral lobule (PCL), superior 
temporal gyrus (STG), middle frontal gyrus (MFG), posterior cingulate cortex (PCC), 
fusiform gyrus (FFG), precuneus (PCu), and cuneus (Cu) (see Table 1 and Figure 2). In 
addition, patients showed a decreased cortical thickness in the anterior midcingulate 
cortex (aMCC) compared with healthy controls. 
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Figure 3: Significant cortical thickness differences between patients with CRPS and healthy 
controls. (A) Left hemisphere. Compared to healthy controls, patients exhibited less cortical GM 
in brain regions including the precentral gyrus (PreCG), postcentral gyrus (PoCG), middle frontal 
gyrus (MFG), superior middle gyrus (SMG), fusiform gyrus (FFG), superior parietal gyrus 
(SPG), superior frontal gyrus (SFG), posterior cingulate cortex (PCC), cuneus (Cu), and temporal 
pole (TPo). (B) Right hemisphere. Compared to healthy controls, patients exhibited less cortical 
GM in brain regions including the lateral occipital gyrus (LOG), banks of the superior temporal 
sulcus (Bankssts), precuneus (PCu), superior temporal gyrus (STG), pars triangularis (PTri), 
parahippocampal gyrus (PHG), and lingual (Ling). T-test of 2.50 corresponds to p = 0.05. Colors: 
blue to light blue = significant decrease compared with controls; red to yellow = significant 
increase compared with controls. N=37 (patients); N=35 (controls). CRPS = complex regional 
pain syndrome; GM = gray matter. 
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Table 1. Cortical and subcortical gray matter differences between patients and healthy 
controls. Patients show decreased GM cortical thickness in all regions.  
Brain	  Region	   Vertices/
Voxels	  
	  	  	  	  	  	  MNI	  Coordinates	   T	  
x	   y	   z	  
Cortical	  Thickness:	  Patients	  <	  Controls	  
Left	  Hemisphere	  	   	   	   	   	   	  
Superior	  frontal	  gyrus	   332	   -­‐13	   17	   34	   2.95	  
Superior	  parietal	  cortex	   290	   -­‐17	   -­‐55	   59	   3.72	  
Postcentral	  gyrus	   240	   -­‐60	   -­‐17	   17	   3.40	  
Precentral	  gyrus	   231	   -­‐26	   -­‐13	   51	   2.76	  
Postcentral	  gyrus	   228	   -­‐24	   -­‐36	   59	   2.95	  
Supramarginal	  gyrus	   217	   -­‐61	   -­‐29	   20	   2.41	  
Superior	  parietal	  cortex	   212	   -­‐23	   -­‐83	   27	   3.03	  
Temporal	  pole	   171	   -­‐34	   13	   -­‐35	   3.05	  
Precentral	  gyrus	   165	   -­‐56	   5	   4	   2.76	  
Superior	  frontal	  gyrus	   161	   -­‐7	   11	   64	   2.85	  
Precentral	  gyrus	   161	   -­‐46	   -­‐8	   30	   2.70	  
Posterior	  cingulate	  cortex	   160	   -­‐12	   -­‐16	   38	   2.66	  
Cuneus	   133	   -­‐6	   -­‐82	   31	   2.48	  
Fusiform	  gyrus	   131	   -­‐43	   -­‐63	   -­‐16	   2.54	  
Superior	  frontal	  gyrus	   125	   -­‐10	   -­‐12	   50	   2.59	  
Superior	  temporal	  gyrus	   90	   -­‐50	   -­‐8	   -­‐17	   2.35	  
Temporal	  pole	   84	   -­‐44	   2	   -­‐34	   2.39	  
Paracentral	  lobule	   83	   -­‐13	   -­‐28	   48	   2.33	  
Right	  Hemisphere	  	   	   	   	   	   	  
Middle	  frontal	  gyrus	   404	   37	   7	   40	   3.67	  
Supramarginal	  gyrus	   372	   45	   -­‐41	   10	   3.27	  
Superior	  frontal	  gyrus	   340	   8	   13	   63	   2.64	  
Temporal	  pole	   303	   30	   8	   -­‐34	   3.42	  
Lateral	  occipital	  gyrus	   252	   29	   -­‐96	   -­‐1	   2.52	  
Superior	  temporal	  gyrus	   240	   57	   -­‐25	   -­‐1	   2.31	  
Precentral	  gyrus	   222	   50	   6	   27	   3.90	  
Lingual	  gyrus	   192	   9	   -­‐63	   5	   3.22	  
Pars	  triangularis	  gyrus	   179	   51	   34	   -­‐2	   2.83	  
Precentral	  gyrus	   157	   37	   -­‐19	   57	   2.58	  
Parahippocampal	  gyrus	   149	   23	   -­‐24	   -­‐20	   3.47	  
Precuneus	   121	   7	   -­‐50	   54	   2.73	  
Frontal	  pole	  	   100	   31	   40	   21	   2.96	  
Superior	  frontal	  gyrus	   93	   13	   10	   42	   2.62	  
Fusiform	  gyrus	  	   79	   38	   -­‐49	   -­‐19	   2.40	  
T-test of 2.50 corresponds to p = 0.05. N=37 (patients); N=35 (controls). MNI = Monteal 
Neurological Institute. 
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Subcortical Volume 
 There were two significant clusters of subcortical areas that were different 
between patients and controls. Compared with healthy controls, patients exhibited 
reduced GM volume in a cluster that included the left nucleus accumbens (NAc) and 
putamen (Put) and in another cluster that included the left amygdala (Amy) and 
hippocampus (Hippo) (Figure 4). We did not find any subcortical regions with 
significant increased GM volume compared with healthy controls.  
 
Figure 4: Significant subcortical volume differences between patients with CRPS and 
healthy controls. Compared with healthy controls, patients exhibited less subcortical GM 
volume in pain and fear-related brain regions including the left nucleus accumbens (NAc), 
putamen (Put), amygdala (Amy), and hippocampus (Hippo). Colors: blue to light blue = 
significant decrease compared with controls. N=37 (patients); N=35 (controls). CRPS = complex 
regional pain syndrome; GM = gray matter. 
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Influence of Pain-Related Fear Level 
Cortical Thickness 
 There were several differences between high fear patients, non-elevated fear 
patients, and healthy controls. Compared with healthy controls, high fear patients had 
decreased cortical thickness in notable regions that were also found to be significantly 
different when comparing patients and healthy controls. These regions include middle 
frontal gyrus (MFG), superior temporal gyrus (STG), precentral gyrus (PreCG), superior 
frontal gyrus (SFG), superior parietal cortex (SPG), and cuneus (Cu). Unique brain areas 
that showed significant cortical thinning in high fear patients when compared to healthy 
controls include transverse temporal gyrus (TTP), anterior cingulate cortex (ACC), 
paracentral lobule (PCL), and pericalcarine cortex (PCAL). (see Figure 5 and Table 2). 
In addition, ROI analysis revealed that compared with both non-elevated fear patients and 
healthy controls, high fear patients showed a thinner anterior midcingulate cortex 
(aMCC) and pregenual anterior cingulate cortex (pgACC) (Figure 6). High fear patients 
did not have any cortical regions with significant increased GM thickness compared with 
non-elevated fear patients. 
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Figure 5: Significant cortical thickness differences between high fear patients and non-
elevated fear patients. (A) Left hemisphere. Compared to non-elevated fear patients, high fear 
patients exhibited less cortical GM in brain regions including the middle frontal gyrus (MFG), 
precentral gyrus (PreCG), superior parietal gyrus (SPG), transverse temporal gyrus (TTP), 
superior temporal gyrus (STG), and pregenual anterior cingulate cortex (pgACC). (B) Right 
hemisphere. Compared to non-elevated fear patients, high fear patients exhibited less cortical GM 
in brain regions including lateral occipital gyrus (LOG), Cuneus (Cu), superior frontal gyrus 
(SFG), paracentral lobule (PCL), paracalcarine gyrus (PCAL), and lingual (LING). T test of 2.50 
corresponds to p = 0.05. T-test of 2.50 corresponds to p = 0.05. Colors: blue to light blue = 
significant decrease compared with controls; red to yellow = significant increase compared with 
controls. N=37 (patients); N=35 (controls). CRPS = complex regional pain syndrome; GM = gray 
matter. 
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Table 2. Cortical thickness differences between high fear patients and non-elevated fear 
patients. 
Brain	  Region	   Vertices/
Voxels	  
	  	  	  	  	  	  MNI	  Coordinates	   T	  
x	   y	   z	  
Cortical	  Thickness:	  High	  <	  Non-­‐elevated	  
Left	  Hemisphere	  	   	   	   	   	   	  
Middle	  frontal	  gyrus	   288	   -­‐30	   8	   54	   3.11	  
Transverse	  temporal	  gyrus	   168	   -­‐45	   -­‐21	   2	   3.07	  
Superior	  temporal	  gyrus	   147	   -­‐64	   -­‐28	   6	   2.70	  
Precentral	  gyrus	   143	   -­‐24	   -­‐10	   47	   2.67	  
Anterior	  cingulate	  cortex	  	   89	   -­‐11	   21	   29	   2.42	  
Superior	  parietal	  lobule	   87	   -­‐30	   -­‐51	   50	   2.66	  
Right	  Hemisphere	  	   	   	   	   	   	  
Middle	  temporal	  gyrus	   468	   49	   -­‐30	   -­‐10	   2.70	  
Superior	  parietal	  cortex	   330	   20	   -­‐77	   44	   3.58	  
Cuneus	   214	   6	   -­‐68	   16	   2.92	  
Superior	  frontal	  gyrus	   148	   7	   50	   30	   3.15	  
Paracentral	  lobule	   99	   15	   -­‐15	   41	   2.58	  
Lateral	  occipital	  gyrus	   90	   31	   -­‐93	   -­‐13	   2.29	  
Lingual	  gyrus	   88	   21	   -­‐69	   3	   2.52	  
Pericalcarine	  cortex	   79	   8	   -­‐82	   10	   2.62	  
	   	   	   	   	   	  T-test of 2.50 corresponds to p = 0.05. N=37 (patients); N=35 (controls). MNI = Monteal 
Neurological Institute. 
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Figure 6: Significant VBM gray matter differences in high fear patients compared to non-
elevated fear patients and healthy controls. Compared to both non-elevated fear patients and 
healthy controls, high fear patients exhibited less GM in a cluster consisting of the anterior 
midcingulate cortex (aMCC) and the pregenual anterior cingulate cortex (pgACC). Colors: blue 
to light blue = significant decrease compared with controls; red to yellow = significant increase 
compared with controls. N=37 (patients); N=35 (controls). CRPS = complex regional pain 
syndrome; GM = gray matter. 
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Subcortical Volume 
 There were no clusters that showed a significant difference between high fear 
patients and non-elevated fear patients in subcortical regions. However, we found one 
cluster containing the left nucleus accumbens (NAc) and the left putamen (Put) that 
exhibited a significant decrease in GM volume in high fear patients in comparison with 
healthy controls (Figure 7).  
 
Figure 7: Significant subcortical volume differences between high fear patients and healthy 
controls. Compared with healthy controls, high fear patients exhibited less subcortical GM 
volume in a cluster consisting of the nucleus accumbens (NAc) and putamen (Put). Colors: blue 
to light blue = significant decrease compared with controls. N=37 (patients); N=35 (controls). 
GM = gray matter. 
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Correlation of FOPQ Scores with Cortical Thickness in Patients 
 Among patients, we examined the relation between pain-related fear level (FOPQ 
scores) and cortical thickness, controlling for pain level. Higher levels of pain-related fear 
were associated with cortical thinning in clusters found in the left middle frontal gyrus 
(MFG), right paracentral lobule (PCL), and posterior cingulate cortex (PCC). Cortical 
thickening was associated with higher levels of pain-related fear for clusters found in the 
right middle temporal gyrus (MTG) and right inferior parietal gyrus (IPG) (Figure 8 and 
Table 3).   
 
Figure 8: Within patients, significant correlation between cortical thickness and FOPQ 
scores, controlling for average pain level. (A) Left hemisphere. Higher FOPQ scores were 
correlated with less cortical GM in the middle frontal gyrus (MFG). (B) Right hemisphere. Higher 
FOPQ scores were associated with cortical thinning in the paracentral lobule (PCL) and posterior 
cingulate cortex (PCC). Higher FOPQ scores were related to cortical thickening in the middle 
temporal gyrus (MTG) and inferior parietal gyrus (IPG). T test of 2.50 corresponds to p = 0.05. 
Colors: blue to light blue = significant decrease compared with controls; red to yellow = 
significant increase compared with controls. N=37 (patients); N=35 (controls). FOPQ = fear of 
pain questionnaire; GM = gray matter. 
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Table 3. Correlation between cortical thickness and FOPQ scores in patients, controlling 
for average pain rating. 
Brain	  Region	   Vertices/
Voxels	  
	  	  	  	  	  	  MNI	  Coordinates	   T	  
x	   y	   z	  
Cortical	  Thickness	   	   	   	   	   	  
Left	  Hemisphere	  	   	   	   	   	   	  
Middle	  frontal	  gyrus	   138	   -­‐26	   8	   50	   -­‐2.92	  
Right	  Hemisphere	  	   	   	   	   	   	  
Middle	  temporal	  gyrus	   231	   65	   -­‐42	   -­‐5	   3.55	  
Inferior	  parietal	  gyrus	   130	   55	   -­‐52	   37	   2.22	  
Paracentral	  lobule	  	   115	   15	   -­‐16	   41	   -­‐2.75	  
Posterior	  cingulate	  cortex	   84	   8	   6	   39	   -­‐2.34	  
T-test of 2.50 corresponds to p = 0.05. N=37 (patients); N=35 (controls). MNI = Monteal 
Neurological Institute. 
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DISCUSSION 
 
 In this study, we investigated the structural brain differences between patients 
with CRPS and matched controls and determined the degree to which fear level 
influences these differences. Compared with healthy controls, patients with CRPS had 
significant GM differences in pain-related cortical (PreCG, PoCG, PCL, MFG, PCC, 
PCu, and Cu) and subcortical regions (Put, NAc, Amy, and Hippo). Additionally, patients 
with CRPS showed significant GM differences in fear-related cortical areas (STG, PTG, 
frontal pole, and parahippocampal gyrus). Accordingly, our findings suggest that there 
are significant underlying morphometric differences between pediatric patients with 
CRPS and healthy controls. When examining the interplay of pain-related fear level on 
structural differences, high fear patients showed significantly decreased GM volume in 
the ACC compared to non-elevated fear patients and healthy controls. When comparing 
high fear patients with healthy controls, high fear patients exhibited a significant decrease 
in the left NAc and Put. The correlation of fear level with cortical structural changes in 
patients indicated that fear level was positively associated with GM differences in MTG 
and IPG and negatively associated with GM differences in MFG, PCL, and PCC. Taken 
together, children and adolescents with CRPS have altered brain structure compared to 
their healthy peers and pain-related fear levels appear to drive the differences for certain 
brain areas typically associated with fear learning circuitry.   
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Patient Versus Healthy Controls 
 The CRPS-related brain abnormalities involve brain areas that are important for 
somatosensory function, motor planning, pain modulation, and emotional processing. 
Compared with healthy controls, patients had cortical thinning in multiple regions, 
including pain-related areas such as PreCG, PoCG, PCL, MFG, PCC, PCu, and Cu. 
Consistent with previous studies on various chronic pain conditions such as chronic back 
pain, migraine, and fibromyalgia, patients with CRPS demonstrate brain alterations in 
regions located in the pain matrix that exacerbates pain (Borsook et al., 2010). Areas 
involved in motor planning found in PreCG, somatosensory function found in PoCG, and 
chronic pain processing (PCL, MFG, PCu, and Cu) have previously been shown to be 
altered in patients with CRPS (Barad et al., 2014; Juottonen et al., 2002; Maihöfner et al., 
2007; Pleger et al., 2014), and may be associated with symptoms of high levels of 
spontaneous pain, allodynia, hyperalgesia, changes in motor control and limb protection 
and disuse (Bruehl and Chung 2006; Schilder et al., 2013).  
 A previous meta-analysis study by Smallwood and colleagues (2013) examining 
structural brain anomalies in patients with chronic pain revealed significant GM 
decreases in superior temporal gyrus (STG) and the putamen (Put). A possible role of the 
STG is monitoring of mismatches between predicted and actual sensation. Since STG 
receives input from the Put, the observed cortical thinning in STG and reduced volume in 
Put could be due to mismatch between pain expectation and perception, which leads to 
central fatigue (Smallwood et al., 2013).	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 Our results indicated a significant reduction in GM volume of subcortical regions 
in patients compared with healthy controls. ROI analysis showed a left-side specific 
difference in one cluster containing the NAc and Put and another cluster containing the 
Amy and Hippo. These are critical structures involved in the emotion-related limbic 
system, suggesting that patients have an abnormal emotional circuitry (Simons et al., 
2014). The Put is part of the corpus striatum, which also includes the caudate nucleus and 
globus pallidus (http://healthline.com/human-body-maps). Recent evidence has 
implicated Put as playing a key role in operant conditioning and tracks how likely the 
conditioning stimuli lead to the correct response (Brovelli et al., 2011). The NAc is well 
known as being involved in the reward and motivation circuitry. An abnormal alteration 
of the NAc and Put may suggest impaired instrumental learning and decision-making in 
patients. 
As we expected, key regions in the fear circuitry, such as the Amy and Hippo, 
show significant differences in patients when compared compared controls. A decrease in 
Amy GM volume may be a result of “emotional blunting,” a condition seen in chronic 
pain patients in which inhibition from interneurons are constantly activated by consistent 
nociceptive input (Izquierdo et al., 2005). An intact hippocampus is needed to maintain 
conditioned learning as well as extinction. However, neuropathic injuries to the Hippo 
dramatically inhibit extinction, therefore prolonging fear learning (Mansour et al., 2014). 
Atrophy of Hippo GM volume may indicate a reduced ability in patients to properly 
undergo fear extinction and may extend fear-learning beyond specific cues and into 
associated context.  
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Influence of Pain-Related Fear Level 
 To our knowledge, this is the first imaging study to investigate the extent to which 
fear level influences brain structural differences in pediatric CPRS patients. When 
examining structural brain alterations within CRPS patient groups, we found significant 
correlation between fear levels as measured by FOPQ scores and cortical thinning in the 
middle frontal gyrus (MFG), paracentral lobule (PCL), and posterior cingulate cortex 
(PCC) and cortical thickening in the middle temporal gyrus (MTG) and inferior parietal 
gyrus (IPG). ROI analysis revealed a significant decrease in left Putnam (Put) and 
nucleus accumbens (NAc) volume in high fear patients compared with healthy controls, 
as well as a smaller anterior midcingulate cortex (aMCC) and pregenual anterior 
cingulate (pgACC) volume in high fear patients compared with both non-elevated fear 
patients and healthy controls.  
The anatomical area of middle frontal gyrus (MFG) corresponds to the functional 
region of dorsolateral prefrontal cortex (dlPFC). Because the reduction of dlPFC 
thickness has been found in other types of pain conditions (Apkarian et al., 2004), this 
effect may not be unique to CRPS pathophysiology. The dlPFC is involved in cognition 
and executive functions in addition to pain modulation through top-down cognitive 
control. It is possible that GM atrophy may be a result of constant sensory input from 
regions such as the thalamus (Mesulam, 1998). In the context of pain, a thinning of the 
dlPFC seems to be more associated with sustained abnormal nociceptive input to the 
brain than reflecting a pre-existing defective pain inhibitory mechanism (Barad et al., 
2013). In Erpelding and colleague’s study, patients with CRPS had a significantly 
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decreased dlPFC when compared to healthy control. However, post-treatment analysis 
revealed a normalization of such alterations, suggesting that brain changes observed in 
dlPFC structure are likely related to presence of disease state and reversal of these 
changes reflect patients’ improvement following treatment (Erpelding et al., 2014). 
Results from our analysis showed that cortical thinning in dlPFC was related to 
increased pain-related fear in patients. In a study conducted by Wheelock and colleagues 
(2014) on threat-learning, the dlPFC is implicated in maintaining attentional resources in 
preparation for threat. The dlPFC showed stronger connectivity to other brain regions, 
including the amygdala and hippocampus, during predictable threats compared with 
unpredictable threats. Further findings correlating dlPFC connectivity with anxiety scores 
suggest that individuals with higher negative affect may require greater dlPFC 
connectivity to coordinate brain activity than individuals with low negative affect 
(Wheelock, 2014). Therefore, it is possible that the cortical thickness changes in dlPFC 
seen in high fear patients with chronic pain are a result of prolonged engagement of 
proactive cognitive processes in preparation to threat (i.e. pain) exposure.  
 ROI analysis showed significant reduction in aMCC volume in all three 
comparisons. Patients showed decreased aMCC volumes when compared with healthy 
controls. Furthermore, when analyzing within patients, high fear patients exhibited 
smaller aMCC volumes when compared to both healthy controls and non-elevated fear 
patients, suggesting that fear levels are associated with greater volume changes in the 
aMCC. The aMCC has a key role in cognitive aspects of movement generation 
(Hoffstaedter et al., 2014). It is possible that patients show atrophy in aMCC because of 
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increased motivation for limb protection and disuse, perpetuated by pain expectation of 
the affected limb. In a study by Vogt and colleagues, pain activity that was coupled with 
fear increased activation in the aMCC. aMCC has also been activated during anxiety 
related aversive conditional stimuli and pain anticipation (Buchel et al., 1998, Chua et al., 
1999), suggesting that noxious activation in aMCC is associated with fear and anxiety 
that are critical to avoidance behaviors (Vogt et al., 2003). Taken together, alterations in 
the aMCC seem to be associated with increased pain-related fear and may be responsible 
for certain pain symptoms implicated in CRPS. 
In a study conducted by Maihöfner and colleagues, patients with CRPS who had 
significant cortical reorganization were given treatment that consisted of physical therapy 
and anti-infammatory medication. After one year, there was a significant reduction in 
reported pain that correlated with the amount of cortical normalization (Maihöfner et al., 
2004). These results demonstrate the relationship between clinical improvements and 
observed cortical normalization in patients with CRPS. Similarly, if brain alterations are 
assumed to be an indication of disease state, which are amplified by associated fear 
levels, it may be possible to normalize such brain structural changes by providing therapy 
that diminishes pain-related fear.  
 
Limitations 
 There were several limitations in this study. We used two different methods of 
data analysis for cortical and subcortical regions, FreeSurfer and FSL-VBM, respectively. 
FreeSurfer uses a surface-based method to calculate vertices at each surface, which 
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“experience has shown results in a much better matching of homologous cortical regions 
than volumetric techniques” (www.surfer.nmr.mgh.harvard.edu). Although FreeSurfer 
was successful in extracting graphical representation of cortical changes, it was not 
possible to do so with subcortical volumes. On the other hand, FSL-VBM analyzes data 
by means of a volumetric-based method that investigate voxel-wise differences in local 
GM volume (www.fsl.fmrib.ox.ac.uk/fsk/fskwiki/FSLVBM). Therefore, the two analyses 
did in fact show differing results for areas in the cingulate cortex because they are two 
different methods of data analysis.  
 A larger sample size would have increased the power of our study. In addition, we 
were unable to obtain FOPQ scores from two patients, and therefore could not include 
them in our assessment of structural brain changes by fear level. However, by conducting 
ROI analysis and using the family-wise error rate (FWE-corrected P) correction p-value 
as a stringent threshold for significance, we believe we increased the power of our study 
to the best of our ability.  
 Another limitation extends to the nature of a cross-sectional design study. When 
examining changes in patients, it is impossible to attribute directionality of brain changes. 
It may be that these abnormal brain alterations were present in patients before the onset 
of the disease state, therefore predisposing these children to acquiring chronic pain 
condition. Conversely, brain abnormalities could be a result of disease symptoms and 
subsequent cognitive, affective, and somatosensory processing, and would thus be valid 
indicators of the patient’s current clinical state. Thus it is important to conduct multi-
modal imaging studies over time that can better inform the interpretation of the results.  
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Future Direction 
 A longitudinal study that assesses brain changes as well as psychological reports 
of chronic pain patients throughout their treatment sessions could correlate treatment 
progress with brain morphometry. Certain brain structure alterations may be able to 
identify characteristics of patients that predict likeliness of developing CRPS and 
examine risk factors of resistance to treatment.  
In addition, a longitudinal study comparing MRI scans of patients before and after 
treatment would affirm better understanding of the causality of abnormal brain alterations 
in relation to the chronic pain condition. It would elucidate the plasticity of pediatric 
brain structures and possible normalization of brain morphometry and functionality after 
treatment. Furthermore, the study can examine patients who recovered and those who did 
not, and retrospectively assess each group’s initial brain structures to establish risk 
factors for non-recovery. A combination of psychological and physical treatment therapy 
targeting diminishing patient fear level may show clinical improvements, which could be 
reflected in reversal of brain alterations.    
 
Conclusion 
 In summary, we found that there are significant structural brain differences in 
pediatric patients with CRPS compared with healthy controls in particular regions that 
involve pain processing and emotional circuitry. Furthermore, differences in key regions 
such as the anterior midcingulate cortex, putamen, and nucleus accumbens are primarily 
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driven by high pain-related fear. In assessing our data, we believe that the use of 
psychology and physical therapy to incorporate components aimed at lowering fear levels 
should result in better treatment responses in patients who exhibit a high level of fear.  
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